Aarti Drugs Q2FY21
· Revenue up 21% to Rs 578.1 crore
· Net profit up 133% to Rs 75.2 crore
· Ebitda up 71% to Rs 116.5 crore
· Ebitda margin at 20.2% from 14.3%
· Declares interim dividend of Rs 2.5 per share Record date for payment of dividend set at November 4, 2020 Board approves raising of funds up to Rs 350 crore through various methods